Key Dates

Related Announcements

• December 9, 2024 - BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed). See NOFO RFA-EY-25-001.

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This Notice is to inform the community that effective immediately NIDA is participating in RFA-EY-25-001: BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed).

The following text (in Bold Italic) has been added to reflect NIDA's participation.

Part 1. Overview Information

Components of Participating Organizations

National Eye Institute (NEI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Mental Health (NIMH)

National Center for Complementary and Integrative Health (NCCIH)

National Institute on Drug Abuse (NIDA)
 

Assistance Listing Number(s)

93.867, 93.213, 93.866, 93.242, 93.865, 93.273, 93.279
 

Section VII. Agency Contacts

Scientific/Research Contact(s)

Martha Flanders, PhD
National Eye Institute (NEI)
Telephone: 301-827-5191
Email: [email protected]

Erin Burke Quinlan, Ph.D.
National Center for Complementary and Integrative Health (NCCIH)
Phone: (301) 451-0636
Email: [email protected]

Changhai Cui, PhD
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-443-1678
Email: [email protected]

Holly Moore, PhD
National Institute on Drug Abuse (NIDA)
Phone: 301-827-7376
Email: [email protected]

All the other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Holly Moore, PhD
National Institute on Drug Abuse (NIDA)
Phone: 301-827-7376
Email: [email protected]